Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Obagi Nu-Derm Clear - HSA Drug Approval Details

Approvals/HSA/Obagi Nu-Derm Clear

Approved

THERAPEUTIC

Obagi Nu-Derm Clear

Pure Tek Corporation (UNITED STATES)🇸🇬 Health Sciences Authority

Approval Date: Aug 13, 2008
Approval ID: 8046efe7fa44f8fb
Company: Pure Tek Corporation (UNITED STATES)
Type: Therapeutic

Approval Details

Approval Id: 8046efe7fa44f8fb
Drug Name: Obagi Nu-Derm Clear
Product Name: Obagi Nu-Derm Clear
Approval Number: SIN13518P
Approval Date: 2008-08-13
Registrant: NEOASIA (S) PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: CREAM
Route Of Administration: TOPICAL
Atc Code: D11AX11
Atc Item Name: hydroquinone
Pharma Manufacturer Name: NEOASIA (S) PTE LTD

Active Ingredients

Hydroquinone

4%

Hydroquinone

4%

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 13, 2008

Approval ID

8046efe7fa44f8fb

Type

Therapeutic

Back to HSA Approvals